R4733

· Hoffmann-La Roche

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for R4733, covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Multiple Ascending Dose Study of R4733 in Patients With Advanced Solid Tumors. [Phase 1]